Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661

Generation of germline-competent induced pluripotent stem cells

Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063

Reprogramming of human somatic cells to pluripotency with defined factors

Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380

Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins

Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626

The modification of mitochondrial energy metabolism and histone of goat somatic cells under small molecules compounds induction

Li, L., Zhang, D., Ren, Y., Ye, S., Zheng, B., Liu, S., Ahmed, J. Z., Li, M., Shi, D., & Huang, B. (2018) · Reproduction in Domestic Animals · doi:10.1111/rda.13304 · Cited by 7

iPSCs as a major opportunity to understand and cure age-related diseases

Lemey, C., Milhavet, O., & Lemaı̂tre, J.-M. (2015) · Biogerontology · doi:10.1007/s10522-015-9579-7 · Cited by 10

NANOG-Dependent Metabolic Reprogramming and Symmetric Division in Tumor-Initiating Stem-like Cells

Machida, K. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-98788-0_8 · Cited by 7

Induction of Pluripotent Stem Cells from Umbilical Cord Blood

Hu, K., & Slukvin, I. I. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201200006 · Cited by 6

Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer

Weddle, C. J., Blancard, M., Uche, N., Pongpamorn, P., Cejas, R. B., & Burridge, P. W. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00837-5 · Cited by 6

p53 safeguards chemical reprogramming of human somatic cells toward pluripotency

Cheng, L., Wang, Y., Yang, Z., Cao, J., Peng, F., Lan, T., Cheng, R., Liu, T., Xia, Z., Guan, J., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.038 · Cited by 6

Culture Environment‐Induced Pluripotency of SACK‐Expanded Tissue Stem Cells

Paré, J., & Sherley, J. L. (2011) · BioMed Research International · doi:10.1155/2011/312457 · Cited by 6

Characterization of p53/p63/p73 and Myc expressions during embryogenesis of the sea urchin

Grant, B., Buitrago, P. A. S., Mercado, B. C., & Yajima, M. (2023) · Developmental Dynamics · doi:10.1002/dvdy.656 · Cited by 7

Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review

Kouroukli, O., Bravou, V., Giannitsas, K., & Tzelepi, V. (2024) · Cancers · doi:10.3390/cancers16040805 · Cited by 7

Energy Landscape Reveals the Underlying Mechanism of Cancer‐Adipose Conversion in Gene Network Models

Chen, Z., Lu, J., Zhao, X., Yu, H., & Li, C. (2024) · Advanced Science · doi:10.1002/advs.202404854 · Cited by 6

From cloned frogs to patient matched stem cells: induced pluripotency or somatic cell nuclear transfer?

Yamada, M., Byrne, J., & Egli, D. M. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.06.007 · Cited by 6

Cyclin-dependent kinase inhibitor p21 does not impact embryonic endochondral ossification in mice

Chinzei, N., Hayashi, S., Hashimoto, S., Kanzaki, N., Iwasa, K., Sakata, S., Kihara, S., Fujishiro, T., Kuroda, R., & Kurosaka, M. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2889 · Cited by 6

Pluripotency-Regulating Networks Provide Basis for Reprogramming

Aksoy, I., & Stanton, L. W. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313050002 · Cited by 6

Chemical Approaches to Controlling Cell Fate

Zhang, M., Li, K., Xie, M., & Ding, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405945-0.00004-1 · Cited by 6

Reciprocity of Action of Increasing Oct4 and Repressing p53 in Transdifferentiation of Mouse Embryonic Fibroblasts into Cardiac Myocytes

Wang, H., Zhao, S., Barton, M. C., Rosengart, T. K., & Cooney, A. J. (2018) · Cellular Reprogramming · doi:10.1089/cell.2017.0031 · Cited by 6

Loss of ZNF677 expression is a predictive biomarker for lymph node metastasis in Middle Eastern Colorectal Cancer

Siraj, A. K., Parvathareddy, S. K., Siraj, N., Alobaisi, K., Aldughaither, S. M., AlManea, H. M., AlHussaini, H. F., Al‐Dayel, F., & Al-Kuraya, K. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-01869-0 · Cited by 6

Convergent mechanisms in pluripotent stem cells and cancer: Implications for stem cell engineering

Mooney, B., Raof, N. A., Li, Y., & Xie, Y. (2013) · Biotechnology Journal · doi:10.1002/biot.201200202 · Cited by 6

Generation of Human Induced Pluripotent Stem Cells Using Genome Integrating or Non-integrating Methods

Šimara, P., Tesařová, L., Paďourová, S., & Koutná, I. (2014) · Folia Biologica · doi:10.14712/fb2014060s10085 · Cited by 6

Chemosuppressive effect of plumbagin on human non-small lung cancer cell xenotransplanted zebrafish

Vinothkumar, R., Ceasar, S. A., & Divyarupa, A. (2017) · Indian Journal of Cancer · doi:10.4103/0019-509x.219580 · Cited by 6

Plasmid-based generation of neural cells from human fibroblasts using non-integrating episomal vectors

Pu, J., Chen, X., Dai, S., Shen, T., & Zheng, T. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.245476 · Cited by 6

ALKBH5 regulates somatic cell reprogramming in a phase-specific manner

Khodeer, S., Klungland, A., & Dahl, J. A. (2022) · Journal of Cell Science · doi:10.1242/jcs.259824 · Cited by 7

Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier

Papapetrou, E. P. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_9 · Cited by 6

Inhibition of lung tumorigenesis by transient reprogramming in cancer cells

Pedrosa, P., Zhang, Z., Nuñez-Quintela, V., Macías, D., Ge, J., Denholm, M., Dyas, A., Estévez‐Souto, V., Lado‐Fernández, P., Gonzalez, P., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07207-2 · Cited by 6

[Current progress and application prospects of induced pluripotent stem cells].

Qin, T., & Miao, X. (2010) · PubMed · Cited by 5

Auxiliary pluripotency-associated genes and their contributions in the generation of induced pluripotent stem cells

Dey, C., Raina, K., Thool, M., Adhikari, P., Haridhasapavalan, K. K., Sundaravadivelu, P. K., Venkatesan, V., Gogoi, R., Selvaraju, S., & Thummer, R. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90059-1.00007-5 · Cited by 5

Cell reprogramming in a predictable manner on the superhydrophobic microwell array chip

Qu, J., Wang, X., Zhang, Y., Hu, R., Hao, Y., Zhao, X., Dong, C., Yang, C., Zhang, W., Sui, J., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122215 · Cited by 5

Progress and bottleneck in induced pluripotency

Zhang, Z., & Xu, Y. (2012) · Cell Regeneration · doi:10.1186/2045-9769-1-5 · Cited by 5

Pluripotency of Male Germline Stem Cells

Kim, S.-T., & Belmonte, J. C. I. (2011) · Molecules and Cells · doi:10.1007/s10059-011-1024-4 · Cited by 5

Tumor Dormancy, Quiescence, and Senescence, Volume 1

Hayat, M. A. (2013) · Springer eBooks · doi:10.1007/978-94-007-5958-9 · Cited by 6

Gadd45a opens up the promoter regions of miR-295 facilitating pluripotency induction

Li, L., Chen, K., Wu, Y., Long, Q., Zhao, D., Ma, B., Pei, D., & Liu, X. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.497 · Cited by 5

p53 Promotes Differentiation of Cardiomyocytes from hiPSC through Wnt Signaling-Mediated Mesendodermal Differentiation

Liu, Y., Zhang, P., Huang, W., Liu, F., Long, D., Peng, W., Dang, X., Zeng, X., & Zhou, R. (2021) · International Journal of Stem Cells · doi:10.15283/ijsc21051 · Cited by 5

Improving Cardiac Reprogramming for Heart Regeneration in Translational Medicine

Liu, L., Guo, Y., Li, Z., & Wang, Z. (2021) · Cells · doi:10.3390/cells10123297 · Cited by 5

Sall4 Guides p53-Mediated Enhancer Interference upon DNA Damage in Mouse Embryonic Stem Cells

Wang, L., Tan, X., Chen, L., Xu, S., Huang, W., Chen, N., Wu, Y., Wang, C., Zhou, D., & Li, M. (2022) · Stem Cells · doi:10.1093/stmcls/sxac058 · Cited by 5

c-Myc/microRNA-17-92 Axis Phase-Dependently Regulates PTEN and p21 Expression via ceRNA during Reprogramming to Mouse Pluripotent Stem Cells

Ishida, T., Ueyama, T., Ihara, D., Harada, Y., Nakagawa, S., Saito, K., Nakao, S., & Kawamura, T. (2023) · Biomedicines · doi:10.3390/biomedicines11061737 · Cited by 5

Synergistic effects of S-alkenylmercaptocysteine (CySSR) species derived from Allium tissue and selenium on inducing apoptosis in ER− breast cancer cells

Zhang, W., Tocmo, R., & Parkin, K. L. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103786 · Cited by 5

TRANSLATIONAL PERSPECTIVES — TRANSIENT EPIGENETIC GENE THERAPY: HAZARD-FREE CELL REPROGRAMMING APPROACH AND RISING ARM OF A UNIVERSAL STEM CELL GENE THERAPY PLATFORM

Bertolotti, R. (2009) · Gene Therapy and Regulation · doi:10.1142/s1568558609000102 · Cited by 5

Collagen complexes increase the efficiency of iPS cells generated using fibroblasts from adult mice

Chang, B., Choi, Y., & Kim, J. (2015) · Journal of Reproduction and Development · doi:10.1262/jrd.2014-081 · Cited by 5

The Cellular Memory Disc of Reprogrammed Cells

Anjamrooz, S. H. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9429-4 · Cited by 5

Connecting the Cell Cycle with Cellular Identity

Chia, G., & Egli, D. M. (2013) · Cellular Reprogramming · doi:10.1089/cell.2013.0041 · Cited by 5

A medium‐throughput analysis of signaling pathways involved in early stages of stem cell reprogramming

Fritz, A. L., Mao, S. R., West, M., & Schaffer, D. V. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25336 · Cited by 5

Tendency of K562 chronic myeloid leukemia cells towards cell reprogramming

Yılmazer, A. (2018) · Turkish Journal of Hematology · doi:10.4274/tjh.2018.0106 · Cited by 5

Induced Pluripotent Stem Cells

Okita, K., & Yamanaka, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385942-6.00018-4 · Cited by 5

Nuclear Power for Axonal Growth

Subang, M. C., & Richardson, P. M. (2009) · Science · doi:10.1126/science.1181038 · Cited by 5

Computational challenges of cell cycle analysis using single cell transcriptomics

Chervov, A., & Zinovyev, A. (2022) · arXiv · doi:10.48550/arxiv.2208.05229 · Cited by 4

Somatic-to-primordial germ cell-like transformation is critical in tumor initiation of mouse breast tumor 4T1 cells.

Ma, Z., Zhang, F., Liu, A., Lin, H., & Liu, C. (2023) · PubMed Central · Cited by 4

Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells

Gao, S., Tao, L., Hou, X., Xu, Z., Liu, W., Zhao, K., Guo, M., Wang, H., Cai, T., Tian, J., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0298-z · Cited by 4

Activation of embryonic/germ cell-like axis links poor outcomes of gliomas

Ma, Z., Zhang, F., Xiong, J., Zhang, H., Lin, H., & Liu, C. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02792-8 · Cited by 4

A rapid and stable spontaneous reprogramming system of Spermatogonial stem cells to Pluripotent State

Wei, R., Zhang, X., Li, X., Wen, J., Liu, H., Fu, J., Li, L., Zhang, W., Liu, Z., Yang, Y., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01150-z · Cited by 4

Induced Pluripotent Stem Cell-Derived Fibroblasts Efficiently Engage Senescence Pathways but Show Increased Sensitivity to Stress Inducers

Goyer, M., Désaulniers-Langevin, C., Sonn, A., Nehmo, G. M., Lisi, V., Benabdallah, B., Raynal, N. J. ‐., & Beausejour, C. M. (2024) · Cells · doi:10.3390/cells13100849 · Cited by 4

MDM4 enables efficient human iPS cell generation from PBMCs using synthetic RNAs

Nakagawa, M., Nogi, M., Doi, H., Hayashi, R., Katayama, T., Ohno, H., Mochizuki, M., Hayashi, K., & Saito, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-16446-y · Cited by 4

Genetic and Epigenetic Instability of Human Pluripotent Stem Cells

Chung, T., Thakar, N. Y., & Wolvetang, E. (2011) · The Open Stem Cell Journal · doi:10.2174/1876893801103010052 · Cited by 53

Transient folate deprivation in combination with small-molecule compounds facilitates the generation of somatic cell-derived pluripotent stem cells in mice

Hu, W., Yan, Q., Yu, F., Qiu, Z., & Zhang, S. (2014) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-014-1249-5 · Cited by 4

Gene expression profiling of somatic and pluripotent cells reveals novel pathways involved in reprogramming

Cai, Y., Dai, X. H., Zhang, Q., Hu, R., & Dai, Z. M. (2015) · Genetics and Molecular Research · doi:10.4238/2015.october.5.21 · Cited by 4

Pathology and Molecular Pathology of Brain Cancer

Ligon, K. L., Wilkinson, K., & Stiles, C. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_16 · Cited by 4

Transient oncogenes

Lenz, G. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.08.012 · Cited by 4

Human Mutations Affecting Reprogramming into Induced Pluripotent Stem Cells

Hayashi, Y. (2017) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2017.1.31 · Cited by 4

Functional Role of Circular RNA in Regenerative Medicine

Cao, R. Y., Dai, Q., Li, Q. X., & Yang, J. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1426-1_24 · Cited by 4

Cancer origin in committed versus stem cells: Hypothetical antineoplastic mechanism/s associated with stem cells

Torres-Montaner, A. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.01.003 · Cited by 4

What Is Regenerative Medicine?

Prescott, C., & Polak, J. M. (2010) · CRC Press eBooks · doi:10.1201/b10346-8 · Cited by 4

The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient

Li, Y., Li, T., Tang, Y., Zhan, Z., Ding, L., Song, L., Yu, T., Yang, Y., Ma, J., Zhang, Y., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234262 · Cited by 4

Gain-of-function oncogenic mutations in TP53 enhance defined factor-mediated cellular reprogrammingPreprint

Moon, J., Ishii, H., Dewi, D. L., Kano, Y., Yamamoto, K., Nishikawa, S., Fujiwara, Y., Doki, Y., & Mori, M. (2011) · Nature Precedings · doi:10.1038/npre.2011.5681.1 · Cited by 4

Real-time RT-PCR v1Preprint

Wang, Y. J. (2017) · doi:10.17504/protocols.io.iencbde · Cited by 4

Single-Cell Phylogenetic Tracing Maps the Landscape of Human Tumor Immune Cell Plasticity Driven by Microenvironment Factors-Mediated Epigenetic ReprogrammingPreprint

Wei, C., Dong, L., Xiong, S., Tang, Y., Yu, P., Liu, W., & Cheng, L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.28.538645 · Cited by 4

Attenuating iPSC reprogramming stress with dominant-negative BET peptides

Hossain, M. E., Cevallos, R. R., Zhang, R., & Hu, K. (2022) · iScience · doi:10.1016/j.isci.2022.105889 · Cited by 3

Direct cardiac reprogramming: A new technology for cardiac repair

Brlecic, P. E., Bonham, C. A., Rosengart, T. K., & Mathison, M. N. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.03.008 · Cited by 3

In Pursuit of Porcine Pluripotent Stem Cells for Autologous Cell Therapy

Verma, V., Mehta, A. K., Pal, S., Kumar, M., Singh, B., Kumar, A., & Gautam, S. K. (2014) · Stem Cell Discovery · doi:10.4236/scd.2014.44012 · Cited by 3

Repressors of reprogramming

Popowski, M. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i3.541 · Cited by 3

Cell fate conversion: a chromatin remodeling checkpoint revealed

Zaret, K. S. (2017) · Cell Research · doi:10.1038/cr.2017.44 · Cited by 3

PHENOTYPIC FEATURES OF ENDOMETRIAL TUMORS IN PATIENTS WITH FAMILY HISTORY OF CANCER

Buchynska, L. G., Iurchenko, N. P., Glushchenko, N. М., & Nesina, I. P. (2017) · Experimental Oncology · doi:10.31768/2312-8852.2017.39(4):312-318 · Cited by 3

Efficient reprogramming of human fibroblasts using RNA reprogramming with DAPT and iDOT1L under normoxia conditions

Morita, K., Nakamura, A., Machida, M., Kawasaki, T., Nakanishi, R., Ichida, J. K., Iwata, T., Umezawa, A., & Akutsu, H. (2022) · Regenerative Therapy · doi:10.1016/j.reth.2022.09.002 · Cited by 3

A Narrative Review of the TP53 and Its Product the p53 Protein

Foroutan, B. (2023) · OBM Genetics · doi:10.21926/obm.genet.2302185 · Cited by 8

Reprogramming Cell Identity: Past Lessons, Challenges, and Future Directions

Silva, J. (2023) · Cellular Reprogramming · doi:10.1089/cell.2023.0100 · Cited by 3

Lentiviral Reprogramming of A-T Patient Fibroblasts to Induced Pluripotent Stem Cells

Nayler, S., Kozlov, S., Lavin, M. F., & Wolvetang, E. J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6955-5_29 · Cited by 3

The Dark Side of Cellular Plasticity: Stem Cells in Development and Cancer

Abollo‐Jiménez, F., Campos‐Sánchez, E., Sagrera, A., Eugenia, M., Isabel, A., Jimenez, R., & Cobale, C. (2011) · InTech eBooks · doi:10.5772/13969 · Cited by 3

Cell‐intrinsic reprogramming capability: gain or loss of pluripotency in germ cells

Imamura, M., Lin, Z. Y., & Okano, H. (2012) · Reproductive Medicine and Biology · doi:10.1007/s12522-012-0131-z · Cited by 3

Computational Analysis of Transcriptional Circuitries in Human Embryonic Stem Cells Reveals Multiple and Independent Networks

Wang, X., & Guda, C. (2014) · BioMed Research International · doi:10.1155/2014/725780 · Cited by 3

Delineating nuclear reprogramming

Ooi, J., & Liu, P. (2012) · Protein & Cell · doi:10.1007/s13238-012-2920-x · Cited by 3

Establishment of novel embryonic stem (ES) cell lines from OG2/rtTA blastocysts

Yao, H., Jiang, Y., Zhang, Y., Liu, W., Huang, B., Wang, X., & Gao, S. (2011) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.05.007 · Cited by 3

Effect of in vivo administration of reprogramming factors in the mouse liver

Tomokuni, A., Eguchi, H., Hoshino, H., Dewi, D. L., Nishikawa, S., Kano, Y., Miyoshi, N., Tojo, A., Kobayashi, S., Gotoh, N., et al. (2013) · Oncology Letters · doi:10.3892/ol.2013.1418 · Cited by 3

CMD kinetics and regenerative medicine.

Anjamrooz, S. H. (2016) · PubMed Central · Cited by 3

Reprogramming of Notch1-induced acute lymphoblastic leukemia cells into pluripotent stem cells in mice

Zhang, H., Cheng, H., Wang, Y., Zheng, Y., Liu, Y.-J., Liu, K., Xu, J., Hao, S., Yuan, W., Zhao, T., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.57 · Cited by 3

Carcinosarcoma of the stomach: four cases that expand the morphologic spectrum of gastric cancer with a primitive phenotype

Yamazawa, S., & Ushiku, T. (2022) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-022-03307-6 · Cited by 3

Canonical Wnt signaling activation by chimeric antigen receptors for efficient cardiac differentiation from mouse embryonic stem cells

Sogo, T., Nakao, S., Tsukamoto, T., Ueyama, T., Harada, Y., Ihara, D., Ishida, T., Nakahara, M., Hasegawa, K., Akagi, Y., et al. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00258-6 · Cited by 3

Roles of Tumor Suppressor Signaling on Reprogramming and Stemness Transition in Somatic Cells

Cheung, A. K. L., Peng, Y., Lung, H. L., Ko, J. M. Y., Cheng, Y., & Li, M. (2013) · InTech eBooks · doi:10.5772/55712 · Cited by 2

Understanding the Molecular Basis of Heterogeneity in Induced Pluripotent Stem Cells

Manian, K. V., Aalam, S. M. M., Bharathan, S. P., Srivastava, A., & Velayudhan, S. R. (2015) · Cellular Reprogramming · doi:10.1089/cell.2015.0013 · Cited by 3

Recent Developments in Targeting Breast Cancer Stem Cells

Sanchez, Y., & Martín, Á. G. (2011) · Recent Patents on Regenerative Medicine · doi:10.2174/2210296511101010001 · Cited by 3

Induction of Neural Lineages from Mesoderm and Endoderm by Defined Transcription Factors

Wernig, M. (2013) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-36648-2_3 · Cited by 1

Endogenous anticancer mechanism differentiation

Werneck, M. B. F. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s349 · Cited by 2

Role of iPSC-Producing Factors in Pre-Implantation Embryos

Amano, T., & Ko, M. S. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-386541-0.00038-2 · Cited by 2

The progress in the study of reprogramming to acquire the features of stem cells in iPSCs and cancers

Saito, S., Wuputra, K., Kato, K., & Yokoyama, K. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822231-7.00002-3 · Cited by 2

Somatic cell reprogramming for Parkinson's disease treatment

Li, X., Fang, K., & Wang, F. (2025) · Ibrain · doi:10.1002/ibra.12189 · Cited by 3

MicroRNAs in Cancer (An Overview)

Ferracin, M., Călin, G. A., & Negrini, M. (2010) · Springer eBooks · doi:10.1007/978-94-007-0298-1_1 · Cited by 2

The Past, Present and Future of Induced Pluripotent Stem Cells

Tanabe, K., & Takahashi, K. (2011) · InTech eBooks · doi:10.5772/24198 · Cited by 2

Hot topics in stem cells and self‐renewal: 2010

Sharpless, N. E. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00592.x · Cited by 2

Induced pluripotent stem (iPS) cells and endothelial cell generation: SIRT-ainly a good idea!

Moura, R., Fadini, G. P., & Tjwa, M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.06.031 · Cited by 2

TUMOR SUPPRESSOR PATHWAYS AND CELLULAR ORIGINS OF BREAST CANCER: NEW COMPLEXITIES AND NEW HOPES

Jerry, D. J., Griner, N. B., & Tao, L. (2010) · Nano LIFE · doi:10.1142/s179398441000002x · Cited by 2

Peering into the Black Box of Reprogramming to the Pluripotent State

Jackson, S. A., & Sridharan, R. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0014-y · Cited by 2

[Stem cells, cancer and P53].

Salamanca-Gómez, F. (2009) · PubMed · Cited by 2

DNA Repair in Normal Stem Cells

Momčilović, O., & Schatten, G. P. (2012) · Springer eBooks · doi:10.1007/978-94-007-4590-2_4 · Cited by 2

p53: Guardian of reprogramming

Ménendez, S., Camus, S., & Belmonte, J. C. I. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13301 · Cited by 88

The Journal of Experimental Medicine CORRESPONDENCE

Sarig, R., Rivlin, N., Brosh, R., Bornstein, C., Kamer, I., Ezra, O., Molchadsky, A., Goldfinger, N., Brenner, O., Rotter, V., et al. (2013)

The p53–PUMA axis suppresses iPSC generation

Li, Y., Feng, H., Gu, H., Lewis, D. W., Yuan, Y., Zhang, L., Yu, H. M., Zhang, P., Cheng, H., Miao, W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3174 · Cited by 64

Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells

Sarig, R., Rivlin, N., Brosh, R., Bornstein, C., Kamer, I., Ezra, O., Molchadsky, A., Goldfinger, N., Brenner, O. J., & Rotter, V. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100797 · Cited by 162

Context‐Dependent Enhancement of Induced Pluripotent Stem Cell Reprogramming by Silencing Puma

Lake, B. B., Fink, J., Klemetsaune, L., Fu, X., Jeffers, J. R., Zambetti, G. P., & Xu, Y. (2012) · Stem Cells · doi:10.1002/stem.1054 · Cited by 30